RECRUITING

MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.

Official Title

MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)

Quick Facts

Study Start:2017-12-22
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05978466

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Diagnosis of valvular or non valvular atrial fibrillation
  2. 2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder
  1. 1. Age below 18 years.
  2. 2. Clinical evidence that death within 6 months is possible
  3. 3. Inability to consent to the research or sign a consent form
  4. 4. Inability to follow up at the research clinic at least annually for continuity of AF care and management

Contacts and Locations

Study Contact

Edward M Burke
CONTACT
773-432-4888
eddie@corvitahealth.org
Martin C Burke, DO
CONTACT
773-432-4888
mburke@corvitahealth.org

Principal Investigator

Martin C Burke, DO
PRINCIPAL_INVESTIGATOR
Chief Scientific Officer

Study Locations (Sites)

CorVita Science Foundation (NFP)
Chicago, Illinois, 60605
United States

Collaborators and Investigators

Sponsor: CorVita Science Foundation

  • Martin C Burke, DO, PRINCIPAL_INVESTIGATOR, Chief Scientific Officer

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-12-22
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2017-12-22
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • atrial arrhythmia
  • atrial fibrillation
  • stroke
  • bleeding
  • Left Atrial Appendage Occlusion

Additional Relevant MeSH Terms

  • Atrial Fibrillation